X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Divis Laboratories - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs DIVIS LABORATORIES - Comparison Results

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE DIVIS LABORATORIES SUVEN LIFE/
DIVIS LABORATORIES
 
P/E (TTM) x 16.3 18.0 90.4% View Chart
P/BV x 3.0 3.9 77.5% View Chart
Dividend Yield % 1.2 1.6 78.1%  

Financials

 SUVEN LIFE   DIVIS LABORATORIES
EQUITY SHARE DATA
    SUVEN LIFE
Mar-16
DIVIS LABORATORIES
Mar-16
SUVEN LIFE/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs3392,484 13.6%   
Low Rs144918 15.7%   
Sales per share (Unadj.) Rs39.2142.3 27.6%  
Earnings per share (Unadj.) Rs7.541.9 17.8%  
Cash flow per share (Unadj.) Rs8.846.3 18.9%  
Dividends per share (Unadj.) Rs2.0010.00 20.0%  
Dividend yield (eoy) %0.80.6 140.9%  
Book value per share (Unadj.) Rs49.0161.5 30.3%  
Shares outstanding (eoy) m127.28265.47 47.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.212.0 51.5%   
Avg P/E ratio x32.440.6 79.7%  
P/CF ratio (eoy) x27.536.7 75.0%  
Price / Book Value ratio x4.910.5 46.8%  
Dividend payout %26.823.9 112.3%   
Avg Mkt Cap Rs m30,732451,525 6.8%   
No. of employees `0001.03.7 25.7%   
Total wages/salary Rs m4163,649 11.4%   
Avg. sales/employee Rs Th5,236.110,184.4 51.4%   
Avg. wages/employee Rs Th436.5984.1 44.4%   
Avg. net profit/employee Rs Th995.52,998.5 33.2%   
INCOME DATA
Net Sales Rs m4,99537,764 13.2%  
Other income Rs m194848 22.8%   
Total revenues Rs m5,18938,612 13.4%   
Gross profit Rs m1,23314,138 8.7%  
Depreciation Rs m1671,182 14.1%   
Interest Rs m5423 233.6%   
Profit before tax Rs m1,20513,781 8.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2552,662 9.6%   
Profit after tax Rs m95011,119 8.5%  
Gross profit margin %24.737.4 65.9%  
Effective tax rate %21.219.3 109.6%   
Net profit margin %19.029.4 64.6%  
BALANCE SHEET DATA
Current assets Rs m4,98630,947 16.1%   
Current liabilities Rs m1,0425,195 20.1%   
Net working cap to sales %79.068.2 115.8%  
Current ratio x4.86.0 80.3%  
Inventory Days Days61117 52.2%  
Debtors Days Days3985 46.0%  
Net fixed assets Rs m3,12617,027 18.4%   
Share capital Rs m127531 24.0%   
"Free" reserves Rs m3,71742,341 8.8%   
Net worth Rs m6,23642,877 14.5%   
Long term debt Rs m4325 9,197.9%   
Total assets Rs m8,07949,684 16.3%  
Interest coverage x23.2595.0 3.9%   
Debt to equity ratio x0.10 63,238.0%  
Sales to assets ratio x0.60.8 81.3%   
Return on assets %12.422.4 55.4%  
Return on equity %15.225.9 58.7%  
Return on capital %18.932.2 58.6%  
Exports to sales %87.585.3 102.6%   
Imports to sales %12.222.9 53.4%   
Exports (fob) Rs m4,37132,198 13.6%   
Imports (cif) Rs m6118,654 7.1%   
Fx inflow Rs m4,66632,270 14.5%   
Fx outflow Rs m9428,775 10.7%   
Net fx Rs m3,72423,496 15.9%   
CASH FLOW
From Operations Rs m92210,379 8.9%  
From Investments Rs m-619-4,135 15.0%  
From Financial Activity Rs m-698-6,241 11.2%  
Net Cashflow Rs m-3963 -11,990.9%  

Share Holding

Indian Promoters % 63.4 52.0 121.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 11.8 -  
FIIs % 0.0 19.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 17.2 212.2%  
Shareholders   37,287 31,796 117.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   TTK HEALTHCARE  ALEMBIC LTD  CIPLA  ELDER PHARMA  UNICHEM LAB  

Compare SUVEN LIFE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Dr Reddy's & Lupin Surge over 2%(Closing)

Indian share markets continued to trade just above the dotted line in the afternoon session in a lackluster day of trading. At the closing bell, the BSE Sensex closed higher by 33 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Aug 22, 2017 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUVEN LIFE - STRIDES SHASUN LTD COMPARISON

COMPARE SUVEN LIFE WITH

MARKET STATS